Barinthus Biotherapeutics plc
BRNS
$0.63
-$0.01-1.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.09M | -14.57M | -21.12M | -19.65M | -20.54M |
| Total Depreciation and Amortization | 309.00K | 101.00K | 1.20M | 1.23M | 628.00K |
| Total Amortization of Deferred Charges | 600.00K | 800.00K | 800.00K | 800.00K | 800.00K |
| Total Other Non-Cash Items | 2.50M | 4.40M | 3.21M | 2.85M | 17.05M |
| Change in Net Operating Assets | 3.44M | -1.46M | -2.20M | -137.00K | 15.15M |
| Cash from Operations | -4.24M | -10.73M | -18.11M | -14.90M | 13.09M |
| Capital Expenditure | 0.00 | 0.00 | -32.00K | -5.00K | -278.00K |
| Sale of Property, Plant, and Equipment | 2.00K | 451.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.00K | 451.00K | -32.00K | -5.00K | -278.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 2.00K | 837.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 2.00K | 837.00K |
| Foreign Exchange rate Adjustments | 418.00K | -1.84M | 5.35M | 3.08M | -7.35M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.82M | -12.11M | -12.80M | -11.82M | 6.30M |